bpc 157 news Big in peptide medicine! 🎉 The FDA advisory panel has voted YES on -157, marking a major milestone for peptide therapy. This decision could make it easier for licensed compounding pharmacies An FDA advisory panel voted

Swartjes M, et al

Sludge Hopper The hopper collects sludge from the hydro-cyclones in a removable bag

Research indicates this peptide modulates endothelial nitric oxide synthase (eNOS) activity, potentially supporting healthy vascular function and blood flow

Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of these incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying

During your initial consultation, we will review your medical history and test your serum vitamin B12 levels to determine if you suffer from vitamin B12 deficiency